Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat

Journal of Neurotrauma

Volumn 21, Issue 5, 2004, Pages 541-547

  Kleindienst, Andrea ^a,c   Harvey, Harlan B ^a   Rice, Ann C ^a   Müller, Christian ^b   Hamm, Robert J ^a   Gaab, Michael R ^c   Bullock, M Ross ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cognitive function; NSE; Rat; S100B protein; Traumatic brain injury

Indexed keywords

CALCIUM BINDING PROTEIN; NEURON SPECIFIC ENOLASE; NEUROTROPHIC FACTOR; PROTEIN S100B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; BRAIN INJURY; COGNITION; CONTROLLED STUDY; CONVALESCENCE; DISEASE MARKER; DRUG EFFECT; DRUG INFUSION; INJURY SCALE; MALE; MAZE TEST; NEUROPROTECTION; NONHUMAN; OUTCOMES RESEARCH; PERCUSSION; RAT;

ANIMALS; BRAIN INJURIES; COGNITION; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; S100 PROTEINS;

EID: 2442652802     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771504774129874     Document Type: Article

References (39)

1. AGELINK, M.W., ANDRICH, J., POSTERT, T., et al. (2001). Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J. Neurol. Neurosurg. Psychiatry 71, 394-396.
2. BARGER, S.W., VAN ELDIK, L.J., and MATTSON, M.P. (1995). S100 beta protects hippocampal neurons from damage induced by glucose deprivation. Brain Res. 677, 167-170.
3. BERGER, R.P., PIERCE, M.C., WISNIEWSKI, S.R., et al. (2002). Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109, E31.
4. beta protein from cultured astrocytes. Glia 27, 275-281.
5. DE KRUIJK, J.R., LEFFERS, P., MENHEERE, P.P., et al. (2001). S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurol. Scand. 103, 175-179.
6. DIXON, C.E., LYETH, B.G., POVLISHOCK, J.T., et al. (1987). A fluid percussion model of experimental brain injury in the rat. J. Neurosurg. 67, 110-119.
7. DONATO, R. (1976). Further studies on the specific interaction of S-100 protein with synaptosomal particulates. J. Neurochem. 27, 439-447.
8. DONATO, R. (1986). S-100 proteins. Cell Calcium 7, 123-145.
9. DONATO, R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668.
10. GREEN, A.J., KEIR, G., and THOMPSON, E.J. (1997). A specific and sensitive ELISA for measuring S-100b in cerebrospinal fluid. J. Immunol. Methods 205, 35-41.
11. HAMM, R.J. (1994). Behavioural assessment of outcome following experimental head injury, in: Neurobiology in the Central Nervous System Trauma. S.K. Salzman and A.I. Faden (eds), Oxford University Press: Oxford, pps. 86-98.
12. HEIZMANN, C.W., FRITZ, G., and SCHAFER, B.W. (2002). S100 proteins: structure, functions and pathology. Front. Biosci. 7, D1356-D1368.
13. HERRMANN, M., CURIO, N., JOST, S., et al. (2001). Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. J. Neurol. Neurosurg. Psychiatry 70, 95-100.
14. HERRMANN, M., JOST, S., KUTZ, S., et al. (2000). Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J. Neurotrauma 17, 113-122.
15. HU, J., FERREIRA, A., and VAN ELDIK, L.J. (1997). S100beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69, 2294-2301.
16. HUTTUNEN, H.J., KUJA-PANULA, J., SORCI, G., et al. (2000). Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275, 40096-40105.
17. INGEBRIGTSEN, T., ROMNER, B., MARUP-JENSEN, S., et al. (2000). The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj. 14, 1047-1055.
18. JACKSON, R.G., SAMRA, G.S., RADCLIFFE, J., et al. (2000). The early fall in levels of S-100 beta in traumatic brain injury. Clin. Chem. Lab. Med. 38, 1165-1167.
19. KLIGMAN, D., and MARSHAK, D.R. (1985). Purification and characterization of a neurite extension factor from bovine brain. Proc. Natl. Acad. Sci. U.S.A. 82, 7136-7139.
20. KRAGH, J., BOLWIG, T.G., WOLDBYE, D.P., et al. (1993). Electroconvulsive shock and lidocaine-induced seizures in the rat activate astrocytes as measured by glial fibrillary acidic protein. Biol. Psychiatry 33, 794-800.
21. LI, Y., WANG, J., SHENG, J.G., et al. (1998). S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J. Neurochem. 71, 1421-1428.
22. MATSUTANI, T., NAGAYOSHI, M., TAMARU, M., et al. (1985). Changes in the levels of neural cell specific proteins in the developing rat brain. Neurochem. Res. 10, 1155-1172.
23. PESKIND, E.R., GRIFFIN, W.S., AKAMA, K.T., et al. (2001). Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem. Int. 39, 409-413.
24. PETROVA, T.V., HU, J., and VAN ELDIK, L.J. (2000). Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures. Brain Res. 853, 74-80.
25. PLEINES, U.E., MORGANTI-KOSSMANN, M.C., RANCAN, M., et al. (2001). S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J. Neurotrauma 18, 491-498.
26. RAABE, A., and SEIFERT, V., (2000). Protein S-100B as a serum marker of brain damage in severe head injury: preliminary results. Neurosurg. Rev. 23, 136-138.
27. RENNELS, M.L., GREGORY, T.F., BLAUMANIS, O.R., et al. (1985). Evidence for a "paravascular" fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 326, 47-63.
28. RICKMANN, M., WOLFF, J.R., and MEYER, D.L. (1995). Expression of S100 protein in the vestibular nuclei during compensation of unilateral labyrinthectomy symptoms. Brain Res. 688, 8-14.
29. ROTHOERL, R.D., BRAWANSKI, A., and WOERTGEN, C. (2000). S-100B protein serum levels after controlled cortical impact injury in the rat. Acta Neurochir. (Wien.) 142, 199-203.
30. beta beta with a peptide derived from p53. Biochemistry 37, 1951-1960.
31. beta stimulates glial cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 88, 3554-3558.
32. SHASHOUA, V.E., HESSE, G.W., and MOORE, B.W. (1984). Proteins of the brain extracellular fluid: evidence for release of S-100 protein. J. Neurochem. 42, 1536-1541.
33. SLEMMER, J.E., MATSER, E.J., DE ZEEUW, C.I., et al. (2002). Repeated mild injury causes cumulative damage to hippocampal cells. Brain 125, 2699-2709.
34. VAN ELDIK, L.J., and ZIMMER, D.B. (1987). Secretion of S-100 from rat C6 glioma cells. Brain Res. 436, 367-370.
35. WHITAKER-AZMITIA, P.M., MURPHY, R., and AZMITIA, E.C. (1990). Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res. 528, 155-158.
36. 2+-dependent manner. Protein Sci. 7, 794-798.
37. WINNINGHAM-MAJOR, F., STAECKER, J.L., BARGER, S.W., et al. (1989). Neurite extension and neuronal survival activities of recombinant S 100 beta proteins that differ in the content and position of cysteine residues. J. Cell Biol. 109, 3063-3071.
38. WOERTGEN, C., ROTHOERL, R.D., and BRAWANSKI, A. (2001). Neuron-specific enolase serum levels after controlled cortical impact injury in the rat. J. Neurotrauma 18, 569-573.
39. ZIMMER, D.B., and VAN ELDIK, L.J. (1986). Identification of a molecular target for the calcium-modulated protein S100. Fructose-1, 6-bisphosphate aldolase. J. Biol. Chem. 261, 11424-11428.